Compass Therapeutics, Inc. (CMPX)
NASDAQ·Healthcare·Biotechnology
$1.81
+1.12%
Mkt Cap $695.58M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | -$900.00K | — | — | -$0.10 | -$0.09 | +10.00% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$0.14 | -$0.08 | +42.86% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.13 | -$0.14 | -7.69% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.12 | -$0.12 | +0.00% | — | — |
| Q1 2025 Feb 27, 2025 | — | — | — | -$0.10 | -$0.11 | -10.00% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.11 | -$0.08 | +27.27% | — | — |
| Q3 2024 Aug 12, 2024 | — | $850.00K | — | -$0.10 | -$0.10 | +0.00% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.11 | -$0.08 | +27.27% | — | — |
| Q1 2024 Mar 21, 2024 | — | $2.84M | — | -$0.09 | -$0.11 | -22.22% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.11 | -$0.08 | +27.27% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$0.08 | -$0.09 | -12.50% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$0.11 | -$0.06 | +45.45% | — | — |
| Q1 2023 Mar 15, 2023 | — | — | — | -$0.11 | -$0.10 | +9.09% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.11 | -$0.12 | -9.09% | — | — |
| Q3 2022 Aug 1, 2022 | — | — | — | -$0.09 | -$0.08 | +11.11% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$0.14 | -$0.07 | +50.00% | — | — |
| Q1 2022 Mar 21, 2022 | — | — | — | -$0.07 | -$0.15 | -114.29% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.12 | -$0.10 | +16.67% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | — | -$1.07 | — | — | — |
| Q2 2021 Apr 30, 2021 | — | — | — | — | -$0.14 | — | — | — |